NCT03804853 Rehabilitation Following Reverse Total Shoulder Arthroplasty

Eligibility & Interventions

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 74 participants in total. It began in 2018-12-12 with a primary completion date of 2026-12-31.

Brief Summary

Reverse total shoulder arthroplasty (RTSA) has been successful in patients with rotator cuff arthropathy, proximal humerus fractures, failed primary total shoulder arthroplasty or failed hemiarthroplasty, and massive irreparable rotator cuff tear. Patients who undergo an RTSA report pain relief and functional range of motion. It has been more than 20 years since the advent of the RTSA construct but an immediate post-operative rehabilitation with active shoulder range of motion has not been prospectively studied in comparison to the traditional post-operative rehabilitation highlighted by Boudreau et al.12 Investigators plan to prospectively follow our patients following RTSA undergoing an immediate active shoulder rehabilitation (IASR) vs traditional rehabilitation in a randomized controlled fashion. Investigators plan to document clinical outcomes, complications and cost effectiveness out to 1 year. The study will hopefully fulfill the Triple Aim model for HealthPartners by improving the health of the population, improve the experience of each individual, and make healthcare affordable by decreasing the total cost of care.

Eligibility Criteria

Inclusion Criteria: * \> 55 years of age. * Candidate for a primary reverse total shoulder arthroplasty. * Capable of completing self-administered questionnaires. * Be willing and able to return for all study-related follow-up procedures. * Able and willing to give informed consent. * Proficient in the English language. Exclusion Criteria: In-Clinic: * Patients planning on undergoing a Primary Reverse Shoulder Total Arthroplasty due to proximal humeral fracture. * Previous shoulder surgery including previous total shoulder arthroplasty or reverse total shoulder arthroplasty or hemiarthroplasty, or instability repairs * Active bacterial infection of the shoulder. * Any concomitant shoulder procedure. * Additional ipsilateral or contralateral upper limb pathology that requires active treatment (i.e. surgery or brace). * Inflammatory arthropathy. * Diagnosed with Rheumatoid arthritis * Diagnosed with gout. * Subject is on chronic anticoagulation due to a bleeding disorder or has taken anticoagulants within 10 days prior to surgery. * Peripheral vascular disease or other vascular disorders that would impair healing. * Peripheral neuropathy or other neurological disorders that may impair the patient to ambulate. * Patient is on workers compensation. * Any condition requiring chemotherapy. * Active tobacco user or former tobacco user who is not free of using tobacco for 8 weeks. * Uncontrolled Diabetes Mellitus with an HbA1C \> 7.5%. * Current drug or alcohol abuse. * Major medical illness (life expectancy less then 2 years or unacceptably high operative risk) * Suspicion of cervical radiculopathy or myelopathy. * Deltoid insufficiency on physical examination. Intra-operative: • Iatrogenic glenoid fracture Post-operative: * Neurological injury of the upper extremity. * Complications from Primary Reverse Shoulder Total Arthroplasty (i.e. post-operative infection, bleeding, hardware failure).

Contact & Investigator

Frequently Asked Questions

Related Trials